Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome

Stein, 1935, Amenorrhea associated with bilateral polycystic ovaries, American Journal of Obstetrics and Gynecology, 29, 181, 10.1016/S0002-9378(15)30642-6 Azziz, 2004, The prevalence and features of the polycystic ovary syndrome in an unselected population, The Journal of Clinical Endocrinology and Metabolism, 89, 2745, 10.1210/jc.2003-032046 Hull, 1981, Ovulation failure and induction, Clinical Obstetrics and Gynaecology, 8, 753, 10.1016/S0306-3356(21)00177-1 Legro, 2000, The genetics of obesity. Lessons for polycystic ovary syndrome, Annals of the New York Academy of Sciences, 900, 193, 10.1111/j.1749-6632.2000.tb06230.x Azziz, 2003, Androgen excess is the key element in the polycystic ovary syndrome, Fertility and Sterility, 80, 252, 10.1016/S0015-0282(03)00735-0 Legro, 2001, Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome, The American Journal of Medicine, 111, 607, 10.1016/S0002-9343(01)00948-2 Carmina, 2003, Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet, Human Reproduction, 18, 2289, 10.1093/humrep/deg440 Azziz, 2004, Androgen excess in women: experience with over 1000 consecutive patients, The Journal of Clinical Endocrinology and Metabolism, 89, 453, 10.1210/jc.2003-031122 Hahn, 2005, Clinical and biochemical characterization of women with polycystic ovary syndrome in north Rhine-Westphalia, Hormone and Metabolic Research, 37, 438, 10.1055/s-2005-870236 Dunaif, 1989, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome, Diabetes, 38, 1165, 10.2337/diabetes.38.9.1165 Legro, 1999, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women, The Journal of Clinical Endocrinology and Metabolism, 84, 165, 10.1210/jc.84.1.165 Carmina, 2004, Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome, Fertility and Sterility, 82, 661, 10.1016/j.fertnstert.2004.01.041 DeUgarte, 2005, Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment, Fertility and Sterility, 83, 1454, 10.1016/j.fertnstert.2004.11.070 Goodarzi, 2003, The importance of insulin resistance in polycystic ovary syndrome, Fertility and Sterility, 80, 255, 10.1016/S0015-0282(03)00734-9 Rebar, 1976, Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome, Journal of Clinical Investigation, 57, 1320, 10.1172/JCI108400 Conway, 1989, Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients, Clinical Endocrinology (Oxford), 30, 459, 10.1111/j.1365-2265.1989.tb00446.x Anttila, 1991, Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease, Fertility and Sterility, 55, 1057, 10.1016/S0015-0282(16)54352-0 van Santbrink, 1997, Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome, Fertility and Sterility, 67, 452, 10.1016/S0015-0282(97)80068-4 Arroyo, 1997, Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity, The Journal of Clinical Endocrinology and Metabolism, 82, 3728, 10.1210/jc.82.11.3728 Taylor, 1997, Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome, The Journal of Clinical Endocrinology and Metabolism, 82, 2248, 10.1210/jc.82.7.2248 Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, 377 Homburg, 2002, What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome, Human Reproduction, 17, 2495, 10.1093/humrep/17.10.2495 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertility and Sterility, 81, 19, 10.1016/j.fertnstert.2003.10.004 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Human Reproduction, 19, 41, 10.1093/humrep/deh098 Azziz, 2005, Diagnostic criteria for polycystic ovary syndrome: a reappraisal, Fertility and Sterility, 83, 1343, 10.1016/j.fertnstert.2005.01.085 Carmina, 2001, Polycystic ovaries in hirsute women with normal menses, The American Journal of Medicine, 111, 602, 10.1016/S0002-9343(01)00979-2 Eden, 1989, Is the polycystic ovary a cause of infertility in the ovulatory woman?, Clinical Endocrinology (Oxford), 30, 77, 10.1111/j.1365-2265.1989.tb03729.x Kousta, 1999, The prevalence of polycystic ovaries in women with infertility, Human Reproduction, 14, 2720, 10.1093/humrep/14.11.2720 Knochenhauer, 1998, Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study, The Journal of Clinical Endocrinology and Metabolism, 83, 3078, 10.1210/jc.83.9.3078 Diamanti-Kandarakis, 1999, A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile, The Journal of Clinical Endocrinology and Metabolism, 84, 4006, 10.1210/jc.84.11.4006 Asuncion, 2000, A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain, The Journal of Clinical Endocrinology and Metabolism, 85, 2434, 10.1210/jc.85.7.2434 Michelmore, 1999, Polycystic ovaries and associated clinical and biochemical features in young women, Clinical Endocrinology (Oxford), 51, 779, 10.1046/j.1365-2265.1999.00886.x US census bureau. Census 2000 Summary File 1, QT-P3. http://factfinder.census.gov/servlet/DatasetMainPageServlet?_program=DEC&_lang=en Hartz, 1979, The association of obesity with infertility and related menstrual abnormalities in women, International Journal of Obesity, 3, 57 Heinonen, 2001, Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study, American Journal of Obstetrics and Gynecology, 184, 289, 10.1067/mob.2001.109596 Escobar-Morreale, 2000, High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus, The Journal of Clinical Endocrinology and Metabolism, 85, 4182, 10.1210/jc.85.11.4182 Conn, 2000, The prevalence of polycystic ovaries in women with type 2 diabetes mellitus, Clinical Endocrinology (Oxford), 52, 81, 10.1046/j.1365-2265.2000.00884.x Peppard, 2001, Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes, Diabetes Care, 24, 1050, 10.2337/diacare.24.6.1050 Allen, 1997, Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women, Fertility and Sterility, 67, 569, 10.1016/S0015-0282(97)80089-1 Goodarzi, 2005, Polycystic ovary syndrome in Mexican–Americans: prevalence and association with the severity of insulin resistance, Fertility and Sterility, 84, 766, 10.1016/j.fertnstert.2005.03.051 King, 2002 Legro, 2002, Molecular progress in infertility: polycystic ovary syndrome, Fertility and Sterility, 78, 569, 10.1016/S0015-0282(02)03275-2 Kahsar-Miller, 2001, Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS, Fertility and Sterility, 75, 53, 10.1016/S0015-0282(00)01662-9 Legro, 1998, Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome, Proceedings of the National Academy of Sciences of the USA, 95, 14956, 10.1073/pnas.95.25.14956 Legro, 2002, Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome, The Journal of Clinical Endocrinology and Metabolism, 87, 2134, 10.1210/jc.87.5.2134 Legro, 2002, Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity, The Journal of Clinical Endocrinology and Metabolism, 87, 2128, 10.1210/jc.87.5.2128 Norman, 1996, Hyperinsulinemia is common in family members of women with polycystic ovary syndrome, Fertility and Sterility, 66, 942, 10.1016/S0015-0282(16)58687-7 Yildiz, 2003, Glucose intolerance, insulin resistance, and hyperandrogenemia in first-degree relatives of women with polycystic ovary syndrome, The Journal of Clinical Endocrinology and Metabolism, 88, 2031, 10.1210/jc.2002-021499 Kaushal, 2004, Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries, Clinical Endocrinology (Oxford), 60, 322, 10.1111/j.1365-2265.2004.01981.x Colilla, 2001, Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first-degree relatives, The Journal of Clinical Endocrinology and Metabolism, 86, 2027, 10.1210/jc.86.5.2027 Ehrmann, 1995, Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus, Journal of Clinical Investigation, 96, 520, 10.1172/JCI118064 Nelson, 1999, Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries, Molecular Endocrinology, 13, 946, 10.1210/me.13.6.946 Dunaif, 2001, Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS), American Journal of Physiology Endocrinology and Metabolism, 281, E392, 10.1152/ajpendo.2001.281.2.E392 Rosenbaum, 1993, Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes, American Journal of Physiology, 264, E197 Ciaraldi, 1992, Cellular mechanisms of insulin resistance in polycystic ovarian syndrome, The Journal of Clinical Endocrinology and Metabolism, 75, 577, 10.1210/jc.75.2.577 Escobar-Morreale, 2005, The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome, Endocrine Reviews, 26, 251, 10.1210/er.2004-0004 Parikh, 2004, Candidate genes for type 2 diabetes, Reviews in Endocrine and Metabolic Disorders, 5, 151, 10.1023/B:REMD.0000021437.46773.26